In FY2027-Q1, revenue rose 11.8% year on year and operating profit increased 16.8%, while the full-year outlook was also revised upward. In FY2027-H1, the key question is whether Q1’s profit-led pace reflects a lasting improvement in first-half cumulative results rather than a one-off factor.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-19 〜 2026-11-06 · 34 of 34 items
Scroll the timeline →
Revenue was ¥91,624 million, representing 24.6% progress against the ¥372,300 million full-year forecast. Can it reach the simple half-year benchmark of ¥186,150 million?
Operating profit was ¥13,663 million, representing 30.4% progress against the ¥45,000 million full-year forecast. Can it exceed the simple half-year benchmark of ¥22,500 million?
Will the upward revision to the full-year forecast, currently ¥2,800 million for revenue and ¥1,200 million for operating profit, widen further or narrow?
Operating profit increased, while ordinary profit fell 10.1% and net profit declined 9.5%. Will this divergence be resolved at the interim stage?
In FY2027-Q1, revenue was ¥91,624 million, up 11.8% year on year, and operating profit was ¥13,663 million, up 16.8%. The full-year forecast has been raised to revenue of ¥372,300 million, operating profit of ¥45,000 million, ordinary profit of ¥47,400 million, and profit attributable to owners of the parent of ¥35,200 million. Q1 progress against the full-year forecast was 24.6% for revenue and 30.4% for operating profit, with profit running ahead of revenue.
The latest upward revision was ¥2,800 million for revenue, ¥1,200 million for operating profit, ¥1,300 million for ordinary profit, and ¥700 million for net profit, compared with the previous forecasts. The company attributed the revision to changing its assumed exchange rates from ¥155 to ¥158 per US dollar and from ¥22 to ¥23 per yuan, as well as to performance above assumptions in the Asia, Japan, and Europe segments. Accordingly, in FY2027-H1 it will be necessary to distinguish the translation effect of yen depreciation from revenue growth driven by actual sales volumes and product competitiveness.
Meanwhile, despite the increase in operating profit, Q1 ordinary profit was ¥14,491 million, down 10.1% year on year, and net profit was ¥10,650 million, down 9.5%. The main reason was said to be the decline from the one-off dividend income recorded in the prior-year quarter, meaning that the improvement at the operating level has not flowed through directly to ordinary profit and net profit. As this adverse comparison will run its course by the interim period, an important point to monitor is whether ordinary profit and net profit return to growth alongside operating profit.
For the FY2027-H1 assessment, ¥186,150 million of revenue and ¥22,500 million of operating profit, half of the full-year forecasts, will be used as simple progress benchmarks. However, these are not the company’s own targets adjusted for seasonality. Rather than applying a mechanical pass-or-fail test, the focus will be on whether Q1’s margin improvement continues into the second quarter and whether the company maintains its full-year forecast after the upward revision.
¥ million
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-11-12 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-11-13 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
164,257JPY m
↗ +18.1% YoYOperating profitCore earnings
19,317JPY m
↗ +8.6% YoYNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 91,624↗ +11.8% YoY | 343,725↗ +11.4% YoY | 253,071↗ +12.0% YoY | 164,257↗ +18.1% YoY | 81,964YoY unavailable | 308,625YoY unavailable | 225,895YoY unavailable | 139,082YoY unavailable |
| Operating profit | 13,663↗ +16.8% YoY | 41,118↗ +5.6% YoY | 33,575↗ +4.1% YoY | 19,317↗ +8.6% YoY | 11,699YoY unavailable | 38,939YoY unavailable | 32,267YoY unavailable | 17,791YoY unavailable |
| Ordinary profit | 14,491↘ -10.1% YoY | 47,971↗ +18.7% YoY | 39,852↗ +19.4% YoY | 24,609↗ +32.4% YoY | 16,127YoY unavailable | 40,430YoY unavailable | 33,383YoY unavailable | 18,590YoY unavailable |
| Net income | 10,650↘ -9.5% YoY | 34,247↗ +10.5% YoY | 28,279↗ +14.0% YoY | 17,652↗ +36.6% YoY | 11,769YoY unavailable | 31,006YoY unavailable | 24,806YoY unavailable | 12,921YoY unavailable |
| Earnings per share | 47.14↘ -9.5% YoY | 151.56↗ +11.4% YoY | 125.15↗ +15.1% YoY | 78.12↗ +37.9% YoY | 52.09YoY unavailable | 136.11YoY unavailable | 108.73YoY unavailable | 56.64YoY unavailable |